Clinical Trial Update: Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days

View source ↗

Summary

A clinical trial investigating whether antibody levels correlate with reduced risk of invasive Group B Streptococcus disease in infants under 90 days has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Group Streptococcus Disease

Snippet

Sponsor: Novartis | Conditions: Invasive Group B Streptococcus Disease | Status: WITHDRAWN